ID
34016
Beskrivning
Study ID: 103974 (primary study) Clinical Study ID: 103974 Study Title: Demonstrate non-inferiority of Men-C immune response of Hib-MenC with Infanrix™-IPV versus a licensed Men-C vaccine with Pediacel™ when given at 2, 3, 4 months and the immunogenicity of Hib-MenC when given as a booster dose at 12-15 months Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00258700 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Haemophilus influenzae Type b, Meningococcal C-Tetanus Toxoid Conjugate Vaccine Trade Name: BIO HIB-MENC-TT; Menitorix Study Indication: Haemophilus influenzae type b; Neisseria Meningitidis
Nyckelord
Versioner (1)
- 2019-01-11 2019-01-11 -
Rättsinnehavare
GSK group of companies
Uppladdad den
11 januari 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Primary & Booster Immunogenicity of Hib-MenC vs a Licensed Men-C Vaccine - 103974
Visit 6: Eligibility Check, Laboratory Test
- StudyEvent: ODM
Beskrivning
Check for Study Continuation
Beskrivning
Did the subject return for Visit 6?
Datatyp
boolean
Beskrivning
If No, please tick ONE most appropriate reason
Datatyp
text
Beskrivning
If Other, please specify
Datatyp
text
Beskrivning
If SAE, record the SAE number
Datatyp
integer
Beskrivning
If non-SAE, please record the AE number
Datatyp
integer
Beskrivning
Please tick who took the decision
Datatyp
text
Beskrivning
Elimination Criteria During The Study
Beskrivning
If any of the criteria become applicable during the study, it will not require withdrawal of the subject from the study but may determine a subject's evaluability in the according-to-protocol (ATP) analysis.
Datatyp
text
Beskrivning
1. Use of any investigational or non-registered product (drug or vaccine) other than the study vaccine(s) during the study period
Datatyp
text
Beskrivning
2. Chronic administration (defined as more than 14 days) or immunodepressants or other imminodefying drugs during the study period.
Datatyp
text
Beskrivning
3. Administration of a vaccine not foreseen by the study protocol during the period starting from 30 days before each dose of vaccine(s) and ending 30 days after
Datatyp
text
Beskrivning
4. Administration of immunoglobulins and/or any blood products during the study period
Datatyp
text
Beskrivning
Laboratory Tests - Blood
Similar models
Visit 6: Eligibility Check, Laboratory Test
- StudyEvent: ODM
Inga kommentarer